Literature DB >> 7816759

Iontophoresis of a model peptide across human skin in vitro: effects of iontophoresis protocol, pH, and ionic strength on peptide flux and skin impedance.

W H Craane-van Hinsberg1, L Bax, N H Flinterman, J Verhoef, H E Junginger, H E Boddé.   

Abstract

This study deals with effects of electrical (current density, frequency and duty cycle) and chemical (buffer pH and ionic strength) conditions on the flux of the octapeptide, 9-desglycinamide, 8-arginine-vasopressin (DGAVP), through dermatomed human skin. A pulsed constant current was applied during iontophoresis. The anode faced the anatomical surface of the skin samples inside the diffusion cells. The resistive and capacitative components of the equivalent electrical circuit of human skin could be calculated by fitting the voltage response to a bi-exponential equation. The skin resistance prior to iontophoresis varied between 20 and 60 k omega.cm2. During iontophoresis a decrease of skin resistance and an increase of the series capacitances was observed, which were most pronounced during the first hour of iontophoresis; thereafter both quantities gradually levelled off to an apparent steady state value. The reduction of the resistance during iontophoresis increased non-linearly with increasing current density between 0.013-0.64 mA.cm-2. The steady state resistance and capacitances did not vary significantly with frequency and duty cycle of the current pulse. There was no pH dependence of skin resistance at steady state. Between pH 4 and 10, the steady state peptide flux had a bell-shaped pH-dependence with a maximum of 0.17 nmol.cm-2.h-1 at pH 7.4, which is close to the I.E.P. of the peptide. Lowering the ionic strength from 0.15 to 0.015 M NaCl increased the steady state flux at pH 5 and pH 8 by a factor 5 to 0.28 +/- 0.21 and 0.48 +/- 0.37 nmol.cm-2.h-1, respectively. Together these observations suggested that DGAVP is transported predominantly by volume flow.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7816759     DOI: 10.1023/a:1018994428375

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

1.  Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes.

Authors:  M J Pikal; S Shah
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

2.  Transdermal iontophoretic delivery of therapeutic peptides/proteins. I: Insulin.

Authors:  Y W Chien; O Siddiqui; Y Sun; W M Shi; J C Liu
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

Review 3.  The role of electroosmotic flow in transdermal iontophoresis.

Authors:  M J Pikal
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

4.  [3H]9-desglycinamide,8-arginine vasopressin: metabolism and in-vivo fate.

Authors:  J Verhoef; H M van den Wildenberg; J W van Nispen
Journal:  J Endocrinol       Date:  1986-09       Impact factor: 4.286

5.  Effects of desglycinamide-arginine-vasopressin (DG-AVP) on memory processes in diabetes insipidus patients and non-diabetic subjects.

Authors:  F Laczi; J M van Ree; A Wagner; Z Valkusz; T Járdánházy; G L Kovács; G Telegdy; J Szilárd; F A László; D de Wied
Journal:  Acta Endocrinol (Copenh)       Date:  1983-02

6.  Radioimmunoassay of desglycinamide-arginine vasopressin and its application in a pharmacokinetic study in the rat.

Authors:  J B van Bree; A G de Boer; M Danhof; J C Verhoef; T B van Wimersma Greidanus; D D Breimer
Journal:  Peptides       Date:  1988 May-Jun       Impact factor: 3.750

  6 in total
  3 in total

1.  Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.

Authors:  J Cázares-Delgadillo; A Naik; A Ganem-Rondero; D Quintanar-Guerrero; Y N Kalia
Journal:  Pharm Res       Date:  2007-04-25       Impact factor: 4.200

2.  Role of appendages in skin resistance and iontophoretic peptide flux: human versus snake skin.

Authors:  W H Craane-van Hinsberg; J C Verhoef; L J Bax; H E Junginger; H E Boddé
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

3.  Effects of ionic strength on passive and iontophoretic transport of cationic permeant across human nail.

Authors:  Kelly A Smith; Jinsong Hao; S Kevin Li
Journal:  Pharm Res       Date:  2009-03-07       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.